MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
37.44
+1.45 (4.03%)
Jul 21, 2026, 4:00 PM EDT - Market closed
MapLight Therapeutics Market Cap
MapLight Therapeutics has a market cap or net worth of $1.7 billion as of July 21, 2026.
Market Cap
1.70B
Enterprise Value
1.39B
1-Year Change
n/a
Ranking
Category
Stock Price
$37.44
ChartMarket Cap Chart
Since the IPO on October 27, 2025, MapLight Therapeutics's market cap has increased from $704.29M to $1.70B, an increase of 141.06%. That is a compound annual growth rate of 232.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 1.70B | 121.47% |
| Dec 31, 2025 | 766.56M | 8.84% |
| Oct 27, 2025 | 704.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunocore Holdings | 1.74B |
| Zymeworks | 1.72B |
| Ascentage Pharma Group International | 1.72B |
| Sarepta Therapeutics | 1.72B |
| Fortrea Holdings | 1.68B |
| MoonLake Immunotherapeutics | 1.64B |
| Maze Therapeutics | 1.62B |
| Recursion Pharmaceuticals | 1.62B |